(Q40676102)

English

Randomized comparison between antibiotics alone and antibiotics plus granulocyte-macrophage colony-stimulating factor (Escherichia coli-derived in cancer patients with fever and neutropenia

scientific article published on January 1996

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

Randomized comparison between antibiotics alone and antibiotics plus granulocyte-macrophage colony-stimulating factor (Escherichia coli-derived in cancer patients with fever and neutropenia (English)

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

0 references

Escherichia coli

1 reference

based on heuristic

author name string

E J Anaissie

1

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

S Vartivarian

2

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

G P Bodey

3

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

C Legrand

4

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

H Kantarjian

5

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

D Abi-Said

6

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

C Karl

7

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

S Vadhan-Raj

8

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

language of work or name

0 references

publication date

1 January 1996

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

American Journal of Medicine

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

100

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

17-23

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

Randomized trial of beta-lactam regimens in febrile neutropenic cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2990006-6

7 January 2021

Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor (1).

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2990006-6

7 January 2021

The role of schedule of antibiotic therapy on the neutropenic patient

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2990006-6

7 January 2021

Effects of bacterially synthesized recombinant human granulocyte-macrophage colony-stimulating factor in patients with advanced malignancy

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2990006-6

7 January 2021

Recombinant granulocyte colony stimulating factor reduces the infectious complications of cytotoxic chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2990006-6

7 January 2021

Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor (2).

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2990006-6

7 January 2021

Recombinant human granulocyte-macrophage colony-stimulating factor after autologous bone marrow transplantation for malignant lymphoma: a British National Lymphoma Investigation double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2990006-6

7 January 2021

Infection risk in patients with small cell lung cancer receiving intensive chemotherapy and recombinant human granulocyte-macrophage colony-stimulating factor

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2990006-6

7 January 2021

Outpatient treatment of febrile episodes in low-risk neutropenic patients with cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2990006-6

7 January 2021

Efficacy and tolerability of recombinant human granulocyte-macrophage colony-stimulating factor in patients with chemotherapy-related leukopenia and fever

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2990006-6

7 January 2021

Identifiers

10.1016/S0002-9343(96)90006-6

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40676102&oldid=2135590337"